Top Buy
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 36 | 0 | 2 | 0 | €136.75 | €236.30 | 72.796% |
| Neurocrine Bioscience | 29 | 0 | 8 | 0 | €127.30 | €140.60 | 10.451% |
| Tenet Healthcare | 28 | 0 | 5 | 0 | €117.00 | €121.69 | 4.011% |
| Jazz Pharmaceuticals plc | 23 | 0 | 3 | 0 | €103.55 | €184.92 | 78.580% |
| Iovance Biotherapeutics Inc. | 20 | 4 | 1 | 1 | €9.91 | €20.35 | 105.285% |
| United Therapeutics | 18 | 0 | 3 | 0 | €249.20 | €288.66 | 15.835% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €19.41 | €26.01 | 33.985% |
| Icon plc | 18 | 0 | 3 | 0 | €287.00 | €319.67 | 11.383% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €38.00 | €84.74 | 123.011% |
| Merit Medical Systems | 17 | 0 | 5 | 0 | €76.00 | €86.90 | 14.338% |
| Insulet Corp. | 16 | 0 | 2 | 0 | €159.25 | €215.54 | 35.345% |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | €40.50 | €50.33 | 24.278% |
| Amedisys Inc. | 14 | 0 | 1 | 0 | €87.00 | €92.26 | 6.046% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €151.35 | €184.76 | 22.075% |
| PTC Therapeutics Inc. | 13 | 5 | 1 | 0 | €28.40 | €41.81 | 47.232% |
| Molina Healthcare | 12 | 1 | 1 | 0 | €326.50 | €366.73 | 12.321% |
| Alkermes plc | 12 | 2 | 0 | 0 | €22.40 | €34.08 | 52.146% |
| CONMED Corp. | 12 | 1 | 4 | 0 | €67.00 | €106.18 | 58.477% |
| Charles River Labs Intl | 10 | 0 | 1 | 0 | €215.20 | €248.57 | 15.507% |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €78.00 | €75.94 | -2.646% |
| Xencor Inc. | 10 | 1 | 2 | 0 | €22.60 | €32.58 | 44.154% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €368.60 | €421.61 | 14.380% |
| Ensign Group Inc. | 9 | 0 | 2 | 0 | €110.00 | €116.99 | 6.357% |
| LivaNova plc | 9 | 0 | 3 | 0 | €56.00 | €66.59 | 18.916% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |